Skip to main content
Scheme 1 | Future Journal of Pharmaceutical Sciences

Scheme 1

From: Quinazolin-4-one derivatives lacking toxicity-producing attributes as glucokinase activators: design, synthesis, molecular docking, and in-silico ADMET prediction

Scheme 1

General scheme for the synthesis of compounds 4–10, 13–19 and 22–28. Reagents and conditions: (i) Acetic anhydride, reflux, 2–3 h, (ii) Propionic anhydride, reflux, 2–3 h, (iii) benzoyl chloride, pyridine, stirring, 1 h, (iv) Ethyl-2-amino-4-thiazoleacetate, pyridine, reflux, 5–6 h, (v) substituted amines, pyridine, sodium acetate, stirring, 0–5 oC, 7–10 h.

Back to article page